Suppr超能文献

碰撞截面 (CCS) 作为补充参数,用于表征人用和兽用药物。

Collision cross section (CCS) as a complementary parameter to characterize human and veterinary drugs.

机构信息

Laboratoire d'Etude des Résidus et Contaminants dans les Aliments (LABERCA), Oniris, INRA UMR 1329, UBL, Nantes, F-44307, France; Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Av. Fuentenueva s/n, Granada, E-18071, Spain.

Laboratoire d'Etude des Résidus et Contaminants dans les Aliments (LABERCA), Oniris, INRA UMR 1329, UBL, Nantes, F-44307, France.

出版信息

Anal Chim Acta. 2018 Dec 28;1043:52-63. doi: 10.1016/j.aca.2018.09.065. Epub 2018 Sep 28.

Abstract

In the context of human and veterinary drugs identification, ion mobility spectrometry (IMS) in combination with mass spectrometry (MS) may provide a relevant complementary piece of information to mass-to-charge ratio (m/z), the so-called collision-cross-section (CCS). Up to now, however, the application of CCS as identification parameter has not been fully investigated due to the reduced number of these drugs that have being characterized in terms of CCS. This work proposes a CCS database for 92 human and veterinary drugs, including eighteen benzimidazoles, eleven 5-nitroimidazoles, eleven aminoglycosides, nineteen quinolones, eighteen β-lactams, ten sulfonamides and five tetracyclines. Among them, 37 drugs have been characterized in terms of CCS for the first time. The CCS values of the other 55 compounds have been compared with those from a recently published database in order to evaluate inter-laboratory reproducibility, which is crucial for the implementation of the CCS as identification parameter. CCS values were measured by traveling wave ion mobility spectrometry (TWIMS) under positive ionization conditions. Nitrogen was used as drift gas in the ion mobility cell. The proposed database covers 173 ions including [M+H] and [M+Na] species. High correlation between m/z and CCS has been observed for [M+H] (R = 0.9518, n = 91) and [M+Na] (R = 0.9135, n = 82) ions. As expected, CCS values for sodium adducts are generally greater than for protonated molecules because they exhibit higher molecular weight. However, sodium adducts of aminoglycosides, β-lactams, and of several quinolones and benzimidazoles, were characterized as more compact ions than their related protonated molecule. In addition, this work describes the fragmentation pattern observed for the studied molecules. For the first time, the main fragment ions for most of the compounds have also been characterized in terms of CCS, involving a total of 238 ions. As proof of concept, for the application of this database to biological matrices, eleven veterinary drugs in bovine urine samples were characterized in terms of CCS, showing that this parameter was not influenced by the matrix.

摘要

在人类和兽医药物鉴定方面,离子淌度谱(IMS)与质谱(MS)联用,可能会为质荷比(m/z),即所谓的碰撞截面(CCS),提供相关的补充信息。然而,由于用于 CCS 特征描述的这些药物数量有限,因此,CCS 作为鉴定参数的应用尚未得到充分研究。本工作提出了一个包含 92 种人类和兽医药物的 CCS 数据库,其中包括 18 种苯并咪唑类药物、11 种 5-硝基咪唑类药物、11 种氨基糖苷类药物、19 种喹诺酮类药物、18 种β-内酰胺类药物、10 种磺胺类药物和 5 种四环素类药物。其中,37 种药物是首次进行 CCS 特征描述。其余 55 种化合物的 CCS 值与最近发表的数据库中的值进行了比较,以评估实验室间的重现性,这对于实施 CCS 作为鉴定参数至关重要。CCS 值通过行波离子淌度谱(TWIMS)在正离子化条件下进行测量。在离子迁移池内,氮气作为漂移气体。所提出的数据库涵盖了 173 种离子,包括 [M+H]+和 [M+Na]+物种。观察到 [M+H]+(R=0.9518,n=91)和 [M+Na]+(R=0.9135,n=82)离子的 m/z 和 CCS 之间存在高度相关性。由于它们具有更高的分子量,因此预期 [M+Na]+加合物的 CCS 值通常大于质子化分子。然而,氨基糖苷类药物、β-内酰胺类药物以及几种喹诺酮类药物和苯并咪唑类药物的 [M+Na]+加合物,被鉴定为比它们相关的质子化分子更紧凑的离子。此外,本工作还描述了所研究分子的碎片模式。首次,还对大多数化合物的主要碎片离子进行了 CCS 特征描述,共涉及 238 种离子。作为概念验证,为了将该数据库应用于生物基质,对牛尿液样品中的 11 种兽医药物进行了 CCS 特征描述,结果表明该参数不受基质的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验